Lista de obras - Sherri L Surman - Dominio Público Uruguay

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

artículo científico publicado en 2007

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge

artículo científico publicado en 2017

A five-residue HIV envelope helper T cell determinant: does this peptide-MHC interaction leave the binding groove half empty?

artículo científico publicado en 2002

A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein

artículo científico publicado en 2007

An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens

artículo científico publicado en 2016

Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens

artículo científico publicado en 2003

Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners

artículo científico publicado en 2016

CD4+ T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection

artículo científico publicado en 2017

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model

artículo científico publicado en 2013

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

artículo científico publicado en 2005

Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin

artículo científico publicado en 2010

Clonally related CD8+ T cells responsible for rapid population of both diffuse nasal-associated lymphoid tissue and lung after respiratory virus infection

artículo científico publicado en 2011

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity ⬇️

artículo científico publicado el 15 de octubre de 2003

Complex sex-biased antibody responses: Estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers

article

Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D.

artículo científico publicado en 2017

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus

artículo científico publicado en 2017

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail

artículo científico publicado en 2008

HIV vaccine rationale, design and testing.

artículo científico publicado en 2005

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

artículo científico publicado en 2009

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

artículo científico publicado en 2008

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

artículo científico publicado en 2010

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

artículo científico publicado en 2009

Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy

artículo científico publicado en 2011

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host

artículo científico publicado en 2014

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

artículo científico publicado en 2004

Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins

artículo científico publicado en 2015

Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

artículo científico publicado en 2013

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut ⬇️

artículo científico publicado el 11 de enero de 2011

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine

artículo científico publicado en 2009

Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice ⬇️

artículo científico publicado el 7 de marzo de 2012

Respiratory Syncytial Virus: Current Progress in Vaccine Development ⬇️

artículo científico publicado el 5 de febrero de 2013

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B

artículo científico publicado en 2007

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

artículo científico publicado en 2014

Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease

artículo científico publicado en 2017

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children

artículo científico publicado en 2014

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats

artículo científico publicado en 2014

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

scientific article published on May 2008

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

artículo científico publicado en 2014

Short communication: The dead cell: a potent escort for HIV type 1 transinfection

artículo científico publicado en 2009

T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry

artículo científico publicado en 2005

Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities

artículo científico publicado en 2008

The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

artículo científico publicado en 2013

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV ⬇️

artículo científico publicado el 14 de marzo de 2012

Vitamin A Deficiency Disrupts Vaccine-Induced Antibody-Forming Cells and the Balance of IgA/IgG Isotypes in the Upper and Lower Respiratory Tract ⬇️

artículo científico publicado el 19 de julio de 2012

Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells

artículo científico publicado en 2015

Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

article

Lista de obras de Sherri L Surman

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge

A five-residue HIV envelope helper T cell determinant: does this peptide-MHC interaction leave the binding groove half empty?

A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein

An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens

Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens

Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners

CD4+ T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin

Clonally related CD8+ T cells responsible for rapid population of both diffuse nasal-associated lymphoid tissue and lung after respiratory virus infection

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity ⬇️

Complex sex-biased antibody responses: Estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers

Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D.

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail

HIV vaccine rationale, design and testing.

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins

Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut ⬇️

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine

Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice ⬇️

Respiratory Syncytial Virus: Current Progress in Vaccine Development ⬇️

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

Short communication: The dead cell: a potent escort for HIV type 1 transinfection

T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry

Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities

The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV ⬇️

Vitamin A Deficiency Disrupts Vaccine-Induced Antibody-Forming Cells and the Balance of IgA/IgG Isotypes in the Upper and Lower Respiratory Tract ⬇️

Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells

Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?